2003
DOI: 10.1182/blood-2002-11-3566
|View full text |Cite
|
Sign up to set email alerts
|

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
64
0
3

Year Published

2004
2004
2014
2014

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 130 publications
(78 citation statements)
references
References 32 publications
11
64
0
3
Order By: Relevance
“…Acute release of vWF markedly decreases CT values. 18,28 Thus, the shortened CT values in MI patients could partly be due to increased vWF levels. However, STEMI patients had significantly shorter CT values than did non-STEMI patients, despite similar vWF:RiCO levels (Table 4).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Acute release of vWF markedly decreases CT values. 18,28 Thus, the shortened CT values in MI patients could partly be due to increased vWF levels. However, STEMI patients had significantly shorter CT values than did non-STEMI patients, despite similar vWF:RiCO levels (Table 4).…”
Section: Discussionmentioning
confidence: 99%
“…18,21 Because different laboratories use different citrate concentrations for sample collection, 21 we determined CT values in blood anticoagulated with either 3.2% or 3.8% citrate. Because CADP-CT was shorter in blood anticoagulated with lepirudin compared with 3.8% citrated blood, 18 we expected shorter CT values at lower citrate concentrations. This was indeed the case (Table 3), but CT values were well correlated between the 2 citrate concentrations (rϭ0.85 and rϭ0.86, PϽ0.0001).…”
Section: Platelet Function Analyzer-100mentioning
confidence: 99%
“…8,145 Desmopressin acetate, an analog of endogenous vasopressin, has been shown in vitro to antagonize platelet dysfunction induced by glycoprotein IIb/IIIa inhibitors and aspirin. 146 Desmopressin acetate has also been reported to be effective in reducing blood loss after cardiac surgery 147 ; however, subsequent studies failed to show marked benefits in improving perioperative hemostasis. 148 A systematic review showed that desmopressin acetate was able to reduce perioperative blood loss but did not minimize perioperative allogeneic erythrocyte transfusion.…”
Section: Platelet Concentratesmentioning
confidence: 99%
“…15,20,22,37,38 Drugs that inhibit platelet function (e.g., aspirin, clopidogrel) and anticoagulants can unmask or induce mild bleeding problems. Desmopressin improves in vitro hemostatic abnormalities induced by anti-platelet therapies 40 but its effectiveness for treating serious bleeding from these drugs is not yet established. Bleeding from Cushing syndrome and thyroid disease require correction of the endocrine abnormality, whereas bleeding from uremia is often managed by correction of anemia.…”
Section: Commonly Faced Problems In Management Of Mild Bleeding Disormentioning
confidence: 99%